1/4 or 25% will have the homozygous recessive genotype. 25% will have the homozygous dominant phenotype. 50% will be heterozygous. We would use a punnet square to figure this out. I’ve attached a picture of one to help you
 
        
        
        
Answer:
The correct answer is case control study. 
Explanation:
A study in which a comparison is made between the patients carrying the disease with the patients not carrying the disease is known as the case-control study. In the mentioned study, the one carrying the disease is termed as cases, and the one that does not possess the disease is termed as controls.  
This form of study is generally done to predict the association between the disease and the risk factor. In case-control studies, only observation is done as no attempt is made to change the course of the condition. The prime objective of the study is to predict the exposure of the risk elements for the individuals present in two groups, that is, controls and cases. This form of study is also called case-referent studies or retrospective studies.  
 
        
             
        
        
        
In metaphase I of meiosis I, the pairs of homologous chromosomes, also known as bivalents or tetrads, line up in a random order along the metaphase plate. The random orientation is another way for cells to introduce genetic variation.
 
        
             
        
        
        
A system that allows pharmacists to automatically substitute with certain pharmacologic or therapeutic alternatives without calling the prescriber each time is known as a Therapeutic interchange.
Therapeutic interchange is the practice of replacing, with the prescribing practitioner's approval, a prescription medication originally prescribed for a patient with an alternative prescription medication. Therapeutic drug monitoring (TDM) is testing that measures the amount of certain medicines in your blood. It is done to make sure the amount of medicine you are taking is both safe and effective.
Therapeutic drug monitoring helps in designing patient-specific dosage regimen, it aids in enhancing the efficacy of drugs, to reduce the toxicity of drugs and for diagnostic purposes, by individualizing drug therapy.
To learn more about Therapeutic interchange , here
brainly.com/question/2141502
#SPJ4
 
        
             
        
        
        
I believe the correct answer from the choices listed above is option B. The statement that would explain the change would be that the <span>product has different chemical properties than the reactants because a chemical reaction occurred. Hope this answers the question. Have a nice day.</span>